KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Ionis Pharmaceuticals (IONS) over the last 16 years, with Q3 2025 value amounting to 0.13%.

  • Ionis Pharmaceuticals' Return on Capital Employed rose 100.0% to 0.13% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.13%, marking a year-over-year increase of 100.0%. This contributed to the annual value of 0.18% for FY2024, which is 200.0% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Return on Capital Employed of 0.13% as of Q3 2025, which was up 100.0% from 0.13% recorded in Q2 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Return on Capital Employed peaked at 0.01% during Q3 2022, and registered a low of 0.22% during Q3 2023.
  • In the last 5 years, Ionis Pharmaceuticals' Return on Capital Employed had a median value of 0.14% in 2023 and averaged 0.12%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 1300bps in 2022, then tumbled by -2300bps in 2023.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Return on Capital Employed stood at 0.01% in 2021, then plummeted by -1326bps to 0.19% in 2022, then grew by 26bps to 0.14% in 2023, then decreased by -24bps to 0.17% in 2024, then rose by 24bps to 0.13% in 2025.
  • Its Return on Capital Employed stands at 0.13% for Q3 2025, versus 0.13% for Q2 2025 and 0.18% for Q1 2025.